The healthcare payments system moves like molasses in February. Providers treat a patient on Monday and get paid sometime between next quarter and never. That 45–120 day lag has been quietly choking hospitals for decades, especially the small-town ones doing God’s work on Walmart budgets. But every system stuck in the past eventually meets its Cylerity.
Cylerity, the Madison-based healthcare fintech, just locked in an oversubscribed $4M seed round led by HealthX Ventures, with backing from C2 Ventures, Upstream Ventures, Wisconsin Investment Partners, and Tundra Angels. They also lined up a $24M debt facility from First Business Bank, a move that says, “we’re not just raising capital, we’re ready to deploy it.”
Co-founders Ryan Wheeler (CEO) and William Lanzen (Chairman & President) didn’t stumble into this. Wheeler’s got 25+ years in healthcare tech, from MedAssets to HealthBridge, with the kind of scars that make a founder unflappable. Lanzen? He’s been decoding healthcare receivables since the Nixon administration, literally, turning medical claims into financial instruments long before fintech was a buzzword. That’s what happens when your résumé starts at JPMorgan Chase in the ’70s and ends with reinventing how hospitals survive.
Cylerity’s platform uses AI to do what bureaucracies can’t, predict reimbursements, model timing, and advance up to 90% of claim value within 24–48 hours. No blanket liens, no staff disruption, just liquidity in motion. When you process 4.5M healthcare claims and manage a $3.5M lending portfolio, that’s not theory, it’s proof of life. Chief Product Officer Kenneth Penkowski led the design thinking that made it happen, turning complex finance into a tool that providers can actually use without a PhD in pain.
Even better, Cylerity graduates from Creative Destruction Labs, the same accelerator responsible for generating CAD $56B in equity value across its alumni. That’s not an incubator; that’s a launchpad for deep tech that doesn’t miss. And HealthX Ventures, led by Mark Bakken, has a résumé to match, early investor in Redox and Medable, two unicorns that changed the digital health game. When Bakken backs you, it’s not charity, it’s data-driven conviction.
This round isn’t just fuel, it’s validation that healthcare liquidity is no longer a back-office problem. It’s infrastructure. The mix of $4M in equity and $24M in debt gives Cylerity both the brains and the balance sheet to scale nationwide, bridging hospitals, EMRs, and banks into one connected financial nervous system.
